Finance

Lists
20B:FRA
BioMark Diagnostics Inc
€0,29
-14,88%
(-0,050) 1D
21 Aug., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 20B...
Open
€0,29
High
€0,29
Low
€0,29
Mkt. cap
53,24Ā m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,42
52-wk low
€0,15
Open
€0,29
High
€0,29
Low
€0,29
Mkt. cap
53,24Ā m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,42
52-wk low
€0,15
About BioMark Diagnostics Inc
CEO-
Employees-
Founded2014
HeadquartersRichmond, Brits-Columbiƫ, Kanada
Sector-
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
38,99Ā k
6,87Ā k
6,92Ā k
7,01Ā k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
112,49Ā k
190,09Ā k
168,62Ā k
196,56Ā k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
193,64Ā k
191,40Ā k
191,88Ā k
59,42Ā k
Operating expense
412,72Ā k
481,76Ā k
526,42Ā k
359,54Ā k
Total operating expenses
412,72Ā k
481,76Ā k
526,42Ā k
359,54Ā k
Operating income
-373,73Ā k
-474,89Ā k
-519,50Ā k
-352,53Ā k
Other non operating income
-16,96Ā k
19,68Ā k
163,16Ā k
150,93Ā k
EBT including unusual items
-416,01Ā k
-481,39Ā k
-380,32Ā k
-199,47Ā k
EBT excluding unusual items
-416,01Ā k
-481,39Ā k
-380,32Ā k
-199,47Ā k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-416,01Ā k
-481,39Ā k
-380,32Ā k
-199,47Ā k
Net profit margin
-1Ā 066,91%
-7Ā 006,16%
-5Ā 499,16%
-2Ā 846,32%
Earnings per share
-
-
-
-
Interest and investment income
4,25Ā k
18,38Ā k
16,22Ā k
15,24Ā k
Interest expense
-9,15Ā k
-6,39Ā k
-22,71Ā k
-25,01Ā k
Net interest expenses
-4,90Ā k
12,00Ā k
-6,49Ā k
-9,76Ā k
Depreciation and amortization charges
100,45Ā k
86,50Ā k
141,02Ā k
54,31Ā k
EBITDA
-369,78Ā k
-470,84Ā k
-515,36Ā k
-348,39Ā k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google-programme